TrialJAMA oncology2017

Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.

Heikki Joensuu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.